Next Issue
September 2021
In the next issue of Pharma Technology Focus we break down some of the biggest stories impacting the global pharmaceutical industry.
When the Covid-19 pandemic began back in 2020, the pharma industry underwent a rapid digital transformation in order to adapt to the remote working conditions necessitated as a result of the virus. However, while this may have improved day-to-day operations, this sudden transition to digital systems may have left manufacturers, suppliers and users vulnerable to a different type of virus.
With cyberthreats on the rise across the healthcare sector, we take a look back at some of the most impactful breaches in recent years to find out what companies can learn from previous cyberattacks.
Also, we find out how the pharma industry is working to reduce the impact of alcohol abuse and the conditions that may arise as a consequence of excessive drinking. Plus, we get the latest insight and analysis from GlobalData.
EDITORIAL
Editor | Eloise McLennan
Writers | Abi Millar, Chloe Kent, Darcy Jimenez, Barbara Peralta
Magazine Designer | Marzia Del Gaone
Graphic Designers | Anett Arc, Ashley McPherson, Tyrrell Lowe, Noemi Balint, Maria Gimenez, Filipe Costa, Martina Labaiova, Dimeji Akinkuolie, Will Ingham
Lead Designer | John Hammond
Publisher | Susanne Hauner
Digital Publishing Director | Duncan West
Advertising
Sales Manager | Nimai Amin
+44 (0) 207 936 6453
Pharma Technology focus is powered by h5mag
read past issues of pharma technology focus HERE
Copyright 2021 NRi Digital, a trading division of Verdict Media Ltd. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.